Table 2 Pathophysiology and toxicity effects of CNTsa
Experimental NM effects | Possible pathophysiological outcomes |
---|---|
ROS generationa | Protein, DNA and membrane injury,aoxidative stressb |
Oxidative stressa | Phase II enzyme induction, inflammation,bmitochondrial perturbationa |
Mitochondrial perturbationa | Inner membrane damage,apermeability transition (PT) pore opening,aenergy failure,aapoptosis,aapo-necrosis, cytotoxicity |
Inflammationa | Tissue infiltration with inflammatory cells,bfibrosis,bgranulomas,batherogenesis,bacute phase protein expression (e.g., C-reactive protein) |
Uptake by reticulo-endothelial systema | Asymptomatic sequestration and storage in liver,aspleen, lymph nodes,bpossible organ enlargement and dysfunction |
Protein denaturation, degradationa | Loss of enzyme activity,aauto-antigenicity |
Nuclear uptakea | DNA damage, nucleoprotein clumping,aautoantigens |
Uptake in neuronal tissuea | Brain and peripheral nervous system injury |
Perturbation of phagocytic function,a“particle overload,’’ mediator releasea | Chronic inflammation,bfibrosis,bgranulomas,binterference in clearance of infectious agentsb |
Endothelial dysfunction, effects on blood clottinga | Atherogenesis,athrombosis,astroke, myocardial infarction |
Generation of neoantigens, breakdown in immune tolerance | Autoimmunity, adjuvant effects |
Altered cell cycle regulation DNA damage | Proliferation, cell cycle arrest, senescence Mutagenesis, metaplasia, carcinogenesis |